Dr. Andy Whittamore, a GP and clinical lead at Asthma and Lung UK, shed light on four chronic lung conditions that tend to ...

Patients may also present with expectoration of mucus plugs, hemoptysis, constitutional symptoms and radiological ... along with presence of extensive bronchiectasis consistent with ABPA on ...

Exceeds the Upper End of Guidance Range for Full-Year 2024 with Unaudited Global Revenues of Approximately $363.7 Million-- --2025 Global ARIKAYCE Revenues Expected to be Between $405 Million ...

For individuals with chronic lung conditions, the winter season and the current cold snap poses significant challenges.

Brensocatib targets the underlying cause of inflammation in NCFBE (Non-Cystic Fibrosis Bronchiectasis) by inhibiting neutrophil serine proteases (NSPs). Current treatments only manage symptoms ...

Brensocatib targets the underlying cause of inflammation in NCFBE (Non-Cystic Fibrosis Bronchiectasis) by inhibiting neutrophil serine proteases (NSPs). Current treatments only manage symptoms ...

Data on the cause of bronchiectasis were collected from patient medical records, including symptoms (suppuration and hemoptysis), a history of pulmonary tuberculosis confirmed by diagnostic tests, and ...

“Symptoms include a cough ... then they might also need extra oxygen support.” “Bronchiectasis is a condition where there is damage to the airways and air sacs,” says Whittamore.

Verona Pharma’s Ohtuvayre has a solid market entry, but its valuation is high. Read why VRNA stock remains a buy for ...

Dupixent® is now used to treat over a million patients globally, with continued growth and expansion in multiple indications for diseases in ...